Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025191 · ClinicalTrials.gov registry record · NA
Prison Connect-STI/HIV Prevention Intervention for Couples Affected by Incarceration
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03025191: Completed NA study, sponsored by NYU Langone Health.
NCT03025191 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03025191, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to adapt an existing couples-level HIV prevention intervention for community populations (CONNECT I/II; PI: El-Bassel) to enable implementation among couples affected by incarceration (PRISON CONNECT) and pilot test its feasibility and acceptability among men incarcerated in the Connecticut Department of Correction (CTDOC) and their community-dwelling committed female partners.
Primary Outcome
Questions about how participant feels about the program activities.
Interventions
- BEHAVIORAL Social Support
- BEHAVIORAL Goal Setting
- BEHAVIORAL Speaker/Listener technique
- BEHAVIORAL Problem-Solving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT03025191 record still lists
NCT03025191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Social Support is the first listed.
NCT03025191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03025191 about?
NCT03025191 is a clinical study titled "Prison Connect-STI/HIV Prevention Intervention for Couples Affected by Incarceration". The purpose of this study is to adapt an existing couples-level HIV prevention intervention for community populations (CONNECT I/II; PI: El-Bassel) to enable implementation among couples affected by incarceration (PRISON CONNECT) and pilot test its feasibility and acceptability among men incarcerate...
What is the current status of trial NCT03025191?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-01. Estimated completion is 2017-12.
What interventions are being tested in trial NCT03025191?
The interventions under investigation include: Social Support (BEHAVIORAL), Goal Setting (BEHAVIORAL), Speaker/Listener technique (BEHAVIORAL), Problem-Solving (BEHAVIORAL).
Who is sponsoring clinical trial NCT03025191?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03025191's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia